ライフサイエンスコーパス: societal cost

1 and $128.2 million ($67.2-$231.9 million) in societal costs).

2 erm disability that exacts high personal and societal cost.

3 cause of premature death with a significant societal cost.

4 n with significant morbidity, mortality, and societal cost.

5 (AUDs) affect people at great individual and societal cost.

6 others' rights and represent a considerable societal cost.

7 mmon disorder, has substantial morbidity and societal cost.

8 s debilitating to individuals and has a high societal cost.

9 de mental health disorder, resulting in high societal costs.

10 iours such as tax evasion impose significant societal costs.

11 t of BPD can reduce individual suffering and societal costs.

12 uld improve diabetes care and reduce related societal costs.

13 mately saving substantial direct medical and societal costs.

14 le diseases and save a substantial amount of societal costs.

15 t, intensive treatment utilization, and high societal costs.

16 while also avoiding 8.3 billion EUR(2019) in societal costs.

17 nd work productivity, leading to substantial societal costs.

18 ecosystem states, potentially incurring high societal costs.

19 eading to increased morbidity, mortality and societal costs.

20 on predictions of future lifetime wages and societal costs.

21 health-care-payer cost and 87% of the total societal costs.

22 rect healthcare expenses as well as indirect societal costs.

23 nosis and treatment for reducing MVA-related societal costs.

24 t only is detrimental to health but also has societal costs.

25 curring tremendous emotional, financial, and societal costs.

26 llion in treatment costs and $243 million in societal costs.

27 e of older adults and has large economic and societal costs.

28 lone or standard care and modestly increases societal costs.

29 Ys lost (+ 5.9%), payer costs (+ 22.2%), and societal costs (+ 14.6%) over the 50-year time-horizon c

30 Including societal costs, a longer follow-up period and preparatio

31 ng from a third-party payer perspective, and societal costs also were calculated.

32 ch interventions can come with a significant societal cost and should thus be based on careful analys

33 of breast cancer to evaluate the incremental societal costs and benefits of status quo versus targete

34 ating condition producing great personal and societal costs and for which there is no effective treat

35 w back pain is a common condition, with high societal costs and often ineffectual treatments.

36 This study aimed to estimate the societal costs and potential for cost-effectiveness of 3

37 iveness ratio, net present value of lifetime societal costs, and 10-year nominal government expenditu

38 We contrast the efficacy, societal costs, and generalisability of monoclonal antib

39 -years (QALYs), health care sector costs and societal costs, and incremental cost-effectiveness ratio

40 are associated with considerable morbidity, societal costs, and reduced quality of life.

41 deaths, and $32 (95% UI, $24-$40) million in societal costs annually.

42 Societal costs are enormous.

43 If the reduced societal costs are included both interventions are likel

44 The burden is significantly higher when societal costs are included.

45 and these costs would be even greater if the societal costs are included.

46 n would be higher with the inclusion of such societal costs as lost productivity.

47 nts and providers may not fully consider the societal cost associated with inappropriate antimicrobia

48 ature was reviewed to assess the patient and societal costs associated with age-related macular degen

49 enditures, resulting in no net difference in societal costs associated with managed care.

50 n turn will reduce the enormous personal and societal costs associated with smoking.

51 hat there is a high economic burden and high societal costs associated with SOGICE and identifies add

52 The societal costs associated with vitreoretinal and other o

53 an estimated $5.59 (95% CI, $2.73-$7.91) in societal cost-benefits for contraceptive services vs usu

54 iduals with psychopathy generate substantial societal costs both as a direct financial consequence of

55 City is conducted not only to calculate the societal costs but also to quantify the environmental an

56 isease-19 (COVID-19), entailing considerable societal costs but, at least initially, based on limited

57 PTSD is associated with high individual and societal costs, but identification of predictive markers

58 nd more effective) since it reduced lifetime societal costs by euro592 per patient and increased QALY

59 nt with lactulose could substantially reduce societal costs by preventing MVAs.

60 , which engenders considerable financial and societal costs, calls for an urgent and concerted public

61 07 (95% CI, -$6302 to $2809) in net lifetime societal costs, costs $1312 (95% CI, $222-$2848) per pat

62 kt of PM(2.5)-eq, and 25 billion MEUR(2019) societal costs could be saved, simply by keeping EU cons

63 for QALYs, and much less costly in terms of societal costs (direct and indirect costs and productivi

64 r-related prevalence and high individual and societal costs, dissociation remains widely underappreci

65 Societal cost-effectiveness of a brief prevention progra

66 Our objective was to estimate the societal cost-effectiveness of different therapeutic alt

67 Societal cost-effectiveness of practice-initiated QI eff

68 Screening adherence, societal cost-effectiveness, and optimal risk stratifica

69 Monte Carlo decision model to evaluate the (societal) cost-effectiveness of hepatic metastasectomy i

70 ransition decision model for evaluating the (societal) cost-effectiveness of RF ablation and hepatic

71 By accounting for societal cost estimates for nitrogen losses, we estimate

72 ately 500,000 cases occurring each year at a societal cost exceeding $2.4 billion.

73 The net mean societal cost for bilateral ranibizumab therapy was -$30

74 The distribution of societal costs for adults with mental illnesses enrolled

75 it were possible to completely estimate the societal costs for all acute foodborne diseases and thei

76 Standard costing methodologies estimated the societal costs from 2023 to 2032 of nationwide implement

77 Healthcare and societal costs (healthcare plus lost production and unpa

78 e quotient (IQ) score has broad economic and societal cost implications because intelligence affects

79 d disability will help to place the issue of societal costs in a better perspective.

80 Consequently, the use of societal costs in cost-utility analysis typically result

81 e psychiatric disorder incurring the largest societal costs in developed countries, there is a need t

82 mate quality-adjusted life years (QALYs) and societal costs (in Oakland) from 6 SSB-associated diseas

83 Societal costs included transportation and loss of produ

84 pression imposes large health, economic, and societal costs, including reduced life span and quality

85 Total societal costs, including the cost of IPCC, were lower f

86 althcare costs or $61.9 billion (33.1-103.3) societal costs (incorporating reduced lost productivity

87 Total health care sector and societal costs increased by $130 100 and $127 800, respe

88 Understanding the distribution of societal costs is essential in evaluating health care fi

89 cted to represent significant individual and societal costs: mental health, physical health, harm tow

90 Adding -$476 442 12-year offsetting societal costs netted $314 521 to society per PDS partic

91 Outcomes were health system and societal costs, number of tuberculosis episodes, tubercu

92 However, vaccination resulted in a net societal cost of $11.17 per person compared with no vacc

93 ost $15,994 per patient, with an incremental societal cost of $1365 per patient and incremental cost-

94 .S. population, our model projects an annual societal cost of $7.1 billion owing to productivity loss

95 gnificant economic losses, with an estimated societal cost of 60 billion dollars per year.

96 The societal cost of a single MVA was estimated at $42,100.

97 the global prevalence of ID and the enormous societal cost of developmental disabilities across the l

98 d help improve outcomes and the personal and societal cost of ECOPDs.

99 transmission at one-seventh to one-half the societal cost of hybrid or remote schooling.

100 ncerns regarding unnecessary surgery and the societal cost of low-value healthcare.

101 The societal cost of not implementing this package at a nati

102 may substantially underestimate the overall societal cost of the crisis.

103 siderable scope to reduce the individual and societal cost of the illness.

104 The societal cost of these disorders is enormous.

105 ecent research has shed light on the various societal costs of CeD across the health care continuum.

106 The societal costs of CHD are high, not just in terms of hea

107 role impairment is a major component of the societal costs of epilepsy per se rather than merely due

108 ion of sudden loss of pulse while minimizing societal costs of excess false detections(7).

109 prosecution, the extremely high personal and societal costs of failure-the conviction of innocent peo

110 tive affect and behavior, and the associated societal costs of implementing evidence-based education

111 nd established health utilities; ultimately, societal costs of low vision and blindness were included

112 jor O&G-producing countries when considering societal costs of methane.

113 Because of the rising societal costs of osteoporosis anticipated in coming yea

114 Outcome measures included health care and societal costs of rotavirus and benefits and incremental

115 on suicide epidemiology, the health care and societal costs of suicide, and the costs and efficacy of

116 entry, we calculated the per-drug and total societal costs of these transferrable market exclusivity

117 Despite the enormous societal costs of this incapacitating disorder, it is la

118 and administration, and does not account for societal costs or budget impact of NGIVs.

119 Societal cost per DALY averted was $10, and the cost per

120 normal (non-trial) conditions the total net societal cost per malaria episode averted in using long-

121 The mean annual societal cost per patient (excluding health system costs

122 Societal cost per unit of improvement on the Children's

123 Mean societal costs per patient were $6879 (95% CI, $3393 to

124 ate the primary economic outcome of lifetime societal costs per quality-adjusted life-years (QALYs) g

125 e direct medical cost perspective versus the societal cost perspective associated with a vitreoretina

126 for unilateral cataract surgery, whereas the societal cost perspective average cost-utility ratio was

127 The societal cost perspective for bilateral therapy was -$30

128 sociated with a healthcare intervention, the societal cost perspective generally yields a greater fin

129 The societal cost perspective includes direct medical costs;

130 A societal cost perspective is more likely than the third-

131 performed 11-year and 2-year ophthalmic and societal cost perspective, cost-utility analyses compari

132 The 13-year societal cost perspective, financial return on investmen

133 Taking a societal cost perspective, we did an evaluation of cost-

134 izing average cost-utility analysis with the societal cost perspective.

135 time tradeoff utilities, direct medical and societal cost perspectives, 12-year, 1-year, and 5-year

136 loss of economic productivity will have high societal costs, potentially increasing wealth inequity a

137 The total Medicare-based societal cost reduction was $783 million.

138 The high societal cost reflects the time that patients are willin

139 ssing self-control might reduce a panoply of societal costs, save taxpayers money, and promote prospe

140 Ys (94 per 10,000 residents) and significant societal cost savings (>$100,000 per 10,000 residents) o

141 r overall costs ($869 vs $2363 for TE), with societal cost savings of $1925 (P = .001), and a 71% pro

142 9 billion (2.62 billion to 3.92 billion) and societal cost savings of $2.64 billion (2.13 billion to

143 significant health gains and healthcare and societal cost-savings.

144 ect costs of care for families, and indirect societal costs should be considered in such decisions.

145 Government must focus on the distribution of societal costs since risk-based financing strategies may

146 l organization (NGO) implementer, as well as societal costs such as opportunity costs to mothers and

147 isabling low back pain at considerably lower societal cost than that of usual care.

148 sts call these costs negative externalities, societal costs that are not properly reflected in market

149 in why inequality prevails even as it incurs societal costs that harm everyone.

150 l, patient, quality-of-life preferences, and societal costs, to allow the highest quality, most cost-

151 ars were similar between regimens, but total societal costs varied considerably.

152 The inclusion of societal costs, versus direct medical costs alone, demon

153 physician visits, or lost workdays; the net societal cost was $65.59 per person compared with no vac

154 Despite their high ecological and societal costs, we currently lack theory for predicting

155 During follow-up, return-to-work and other societal costs were documented up to 1 year.

156 Mean societal costs were likewise lower in the high-dose vers

157 Overall societal costs were lower in the ERP group (mean differe

158 Differences in societal costs were somewhat smaller and were not signif

159 al Symptom Rating Scale-IBS version in ICBT, societal costs would be reduced with approximately $300.